A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome

Geetha Achanta, Aneta Modzelewska, Li Feng, Saeed R. Khan, Peng Huang

Research output: Contribution to journalArticle

Abstract

Chalcones and their derivatives have been shown to have potent anticancer activity. However, the exact mechanisms of cytotoxic activity remain to be established. In this study, we have evaluated a series of boronic chalcones for their anticancer activity and mechanisms of action. Among the eight chalcone derivatives tested, 3,5-bis-(4-boronic acid-benzylidene)-1-methyl-piperidin-4- one (AM114) exhibited most potent growth inhibitory activity with IC 50 values of 1.5 and 0.6 μM in 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay and colony formation assay, respectively. The cytotoxic activity of AM114 was shown to be associated with the accumulation of p53 and p21 proteins and induction of apoptosis. Mechanistic studies showed that AM114 treatment inhibited the chymotrypsin-like activity of the 20S proteasome in vitro, leading to a significant accumulation of ubiquitinated p53 and other cellular proteins in whole cells. In vitro studies showed that AM114 did not significantly disrupt the interaction of p53 and murine double minute 2 protein. It is noteworthy that AM114 as a single agent was preferentially toxic to cells with wild-type p53 expression, whereas combination of this compound with ionizing radiation (IR) significantly enhanced the cell-killing activity of IR in both wild-type p53 and p53-null cells. Together, these results indicate that the boronic chalcone derivative AM114 induces significant cytotoxic effect in cancer cells through the inhibition of the cellular proteasome and provide a rationale for the further development of this class of compounds as novel cancer chemotherapeutic agents.

Original languageEnglish (US)
Pages (from-to)426-433
Number of pages8
JournalMolecular Pharmacology
Volume70
Issue number1
DOIs
StatePublished - 2006

Fingerprint

Chalcone
Proteasome Endopeptidase Complex
Chalcones
Ionizing Radiation
Proto-Oncogene Proteins c-mdm2
Boronic Acids
Null Lymphocytes
Poisons
Chymotrypsin
Neoplasms
Proteins
Apoptosis
Growth
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology

Cite this

A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. / Achanta, Geetha; Modzelewska, Aneta; Feng, Li; Khan, Saeed R.; Huang, Peng.

In: Molecular Pharmacology, Vol. 70, No. 1, 2006, p. 426-433.

Research output: Contribution to journalArticle

Achanta, Geetha ; Modzelewska, Aneta ; Feng, Li ; Khan, Saeed R. ; Huang, Peng. / A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. In: Molecular Pharmacology. 2006 ; Vol. 70, No. 1. pp. 426-433.
@article{cd2e96c979d846b1a3bd8d5c6bd074e4,
title = "A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome",
abstract = "Chalcones and their derivatives have been shown to have potent anticancer activity. However, the exact mechanisms of cytotoxic activity remain to be established. In this study, we have evaluated a series of boronic chalcones for their anticancer activity and mechanisms of action. Among the eight chalcone derivatives tested, 3,5-bis-(4-boronic acid-benzylidene)-1-methyl-piperidin-4- one (AM114) exhibited most potent growth inhibitory activity with IC 50 values of 1.5 and 0.6 μM in 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay and colony formation assay, respectively. The cytotoxic activity of AM114 was shown to be associated with the accumulation of p53 and p21 proteins and induction of apoptosis. Mechanistic studies showed that AM114 treatment inhibited the chymotrypsin-like activity of the 20S proteasome in vitro, leading to a significant accumulation of ubiquitinated p53 and other cellular proteins in whole cells. In vitro studies showed that AM114 did not significantly disrupt the interaction of p53 and murine double minute 2 protein. It is noteworthy that AM114 as a single agent was preferentially toxic to cells with wild-type p53 expression, whereas combination of this compound with ionizing radiation (IR) significantly enhanced the cell-killing activity of IR in both wild-type p53 and p53-null cells. Together, these results indicate that the boronic chalcone derivative AM114 induces significant cytotoxic effect in cancer cells through the inhibition of the cellular proteasome and provide a rationale for the further development of this class of compounds as novel cancer chemotherapeutic agents.",
author = "Geetha Achanta and Aneta Modzelewska and Li Feng and Khan, {Saeed R.} and Peng Huang",
year = "2006",
doi = "10.1124/mol.105.021311",
language = "English (US)",
volume = "70",
pages = "426--433",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome

AU - Achanta, Geetha

AU - Modzelewska, Aneta

AU - Feng, Li

AU - Khan, Saeed R.

AU - Huang, Peng

PY - 2006

Y1 - 2006

N2 - Chalcones and their derivatives have been shown to have potent anticancer activity. However, the exact mechanisms of cytotoxic activity remain to be established. In this study, we have evaluated a series of boronic chalcones for their anticancer activity and mechanisms of action. Among the eight chalcone derivatives tested, 3,5-bis-(4-boronic acid-benzylidene)-1-methyl-piperidin-4- one (AM114) exhibited most potent growth inhibitory activity with IC 50 values of 1.5 and 0.6 μM in 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay and colony formation assay, respectively. The cytotoxic activity of AM114 was shown to be associated with the accumulation of p53 and p21 proteins and induction of apoptosis. Mechanistic studies showed that AM114 treatment inhibited the chymotrypsin-like activity of the 20S proteasome in vitro, leading to a significant accumulation of ubiquitinated p53 and other cellular proteins in whole cells. In vitro studies showed that AM114 did not significantly disrupt the interaction of p53 and murine double minute 2 protein. It is noteworthy that AM114 as a single agent was preferentially toxic to cells with wild-type p53 expression, whereas combination of this compound with ionizing radiation (IR) significantly enhanced the cell-killing activity of IR in both wild-type p53 and p53-null cells. Together, these results indicate that the boronic chalcone derivative AM114 induces significant cytotoxic effect in cancer cells through the inhibition of the cellular proteasome and provide a rationale for the further development of this class of compounds as novel cancer chemotherapeutic agents.

AB - Chalcones and their derivatives have been shown to have potent anticancer activity. However, the exact mechanisms of cytotoxic activity remain to be established. In this study, we have evaluated a series of boronic chalcones for their anticancer activity and mechanisms of action. Among the eight chalcone derivatives tested, 3,5-bis-(4-boronic acid-benzylidene)-1-methyl-piperidin-4- one (AM114) exhibited most potent growth inhibitory activity with IC 50 values of 1.5 and 0.6 μM in 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay and colony formation assay, respectively. The cytotoxic activity of AM114 was shown to be associated with the accumulation of p53 and p21 proteins and induction of apoptosis. Mechanistic studies showed that AM114 treatment inhibited the chymotrypsin-like activity of the 20S proteasome in vitro, leading to a significant accumulation of ubiquitinated p53 and other cellular proteins in whole cells. In vitro studies showed that AM114 did not significantly disrupt the interaction of p53 and murine double minute 2 protein. It is noteworthy that AM114 as a single agent was preferentially toxic to cells with wild-type p53 expression, whereas combination of this compound with ionizing radiation (IR) significantly enhanced the cell-killing activity of IR in both wild-type p53 and p53-null cells. Together, these results indicate that the boronic chalcone derivative AM114 induces significant cytotoxic effect in cancer cells through the inhibition of the cellular proteasome and provide a rationale for the further development of this class of compounds as novel cancer chemotherapeutic agents.

UR - http://www.scopus.com/inward/record.url?scp=33745276531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745276531&partnerID=8YFLogxK

U2 - 10.1124/mol.105.021311

DO - 10.1124/mol.105.021311

M3 - Article

C2 - 16636137

AN - SCOPUS:33745276531

VL - 70

SP - 426

EP - 433

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -